Phase II study of amikacin for treatment of non-tuberculous mycobacterium infection.
Phase of Trial: Phase II
Latest Information Update: 15 Nov 2017
At a glance
- Drugs Amikacin (Primary)
- Indications Mycobacterial infections
- Focus Therapeutic Use
- 15 Nov 2017 According to a Matinas BioPharma media release, the company expects to initiate this study in Q4 2018.
- 11 Aug 2017 New trial record
- 08 Aug 2017 According to a Matinas BioPharma media release, the company plans to initiate phase II NTM study in second half of 2018.